Loading, Please Wait...
IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will present at the Cantor Global Healthcare Conference in New York, NY.
|Event:||Cantor Global Healthcare Conference|
|Date:||Monday, October 1, 2018|
|Time:||8:55 AM ET|
|Location:||Intercontinental New York Barclay Hotel, New York, NY|
A live audio webcast of the event can be accessed on the Events & Presentations page of the Investors section of Evolus’s website at http://www.evolus.com, or by following the link below in your web browser. An archived replay of the webcast will be available on Evolus’s website for 30 days after the live event concludes.
Webcast Link: http://wsw.com/webcast/cantor7/eols/
About Evolus, Inc.
Evolus is a company dedicated to aesthetic medicine focused on providing physicians and their patients with expanded choices in aesthetic treatments and procedures. Evolus’ lead candidate DWP-450, also known by the chemical name prabotulinumtoxinA, is a 900 kDa purified botulinum toxin type A complex that was approved by Health Canada for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients under 65 years of age and is being evaluated for marketing approval in the United States and other areas.
Ashwin Agarwal, Evolus
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Kirsten Thomas, The Ruth Group